|
|
Article: Newly Launched Generic Paroxetine will be Primary Care Physicians' Drug of Choice in the Management of Anxiety Disorders; Generic Citalopram Could Also Be Widely Prescribed by Early 2005, According to a New Primary Research Report from Decision Resources.
- Article from:
- PR Newswire
- Article date:
- September 17, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WALTHAM, Mass., Sept. 17 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms for pharmaceutical and health care issues, finds that the recent launch of the first generic paroxetine product in the United States, together with the prospective launch of generic citalopram, will have a more profound effect on prescribing behavior in the U.S. antidepressant market than did the launch in 2001 of generic fluoxetine. The new PhysicianForum report entitled Potential Impact of Generic Citalopram and Paroxetine on the Antidepressant Market finds that the availability of generic paroxetine and citalopram will prompt many physicians to ...
Related newspaper, magazine, and journal articles:
|
|
Article: Decision Resources, Inc. Acquires Arlington Medical ...
PR Newswire;
December 19, 2007 ;
700+ words
...Acquisition Expands Decision Resources, Inc.'s Market Research ... Dec. 19 /PRNewswire/ -- Decision Resources, Inc., one of the world ... AMR by Waltham, MA-based Decision Resources, Inc. will result in a significant ...
|
|